Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 7/7/2020
SIETES contiene 93061 citas

 
 
<< anterior 21 a 40 de 108 siguiente >>
Presentar resultados
Seleccionar todas
21.
Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012;379:1045-55. [Ref.ID 92526]
22. Cita con resumen
Hatcher S, Arroll B. Newer antidepressants for the treatment of depression in adults. BMJ 2012;344:45-9. [Ref.ID 92299]
23.Enlace a cita original Cita con resumen
Malón Musgo MM, Gorricho Mendívil J, Otano Martínez M. Dolor neuropático y tratamiento. Muchas preguntas en el aire. Boletín de Información Farmacoterapéutica de Navarra 2011;19:1-14. [Ref.ID 90774]
24.Enlace a cita original Cita con resumen
Carvajal A, Ortega S, Del Olmo L, Vidal X, Aguirre C, Ruiz B, Conforti A, Leone R, López-Vázquez P, Figueiras A, Ibáñez L. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study. PLoS One 2011;6:e19819. [Ref.ID 90662]
25.
Dhippayom T, Chaiyakunapruk N, Jongchansittho T. Safety of nortriptyline at equivalent therapeutic doses for smoking cessatio: a systematic review and meta-analysis. Drug Saf 2011;34:199-210. [Ref.ID 90106]
26.Tiene citas relacionadas Cita con resumen
Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009;374:1252-61. [Ref.ID 86904]
27.Tiene citas relacionadas
Jensen TS, Finnerup NB. Neuropathic pain treatment: a further step forward. Lancet 2009;374:1218-9. [Ref.ID 86893]
28. Cita con resumen
Sloss A. Prescribing in liver disease. Australian Prescriber 2009;32:32-5. [Ref.ID 85568]
29.Tiene citas relacionadas Cita con resumen
Ramos E, St-André M, Rey E, Oraichi D, Bérard A. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 2008;192:344-50. [Ref.ID 83561]
30. Cita con resumen
Aveyard P, Johnson C, Fillingham S, Parsons A, Murphy M. Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. BMJ 2008;336:1223-7. [Ref.ID 83123]
31. Cita con resumen
Derijks H, Meyboom RHB, Heerdink ER, De Koning FHP, Janknegt R, Lindquist M, Egberts ACG. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol 2008;64:531-8. [Ref.ID 82990]
32.Enlace a cita original
33.
Unützer J. Late-life depression. N Engl J Med 2007;357:2269-76. [Ref.ID 81715]
34.
Aveyard P, West R. Managing smoking cessation. BMJ 2007;335:37-41. [Ref.ID 80608]
35. Cita con resumen
Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet 2006;368:1023-32. [Ref.ID 78031]
36.
Chandra K, Shafiq N, Pandhi P, Gupta S, Malhotra S. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial - The GONIP Trial. Int J Clin Pharmacol Ther 2006;44:358-63. [Ref.ID 77929]
37.
Malone M. Medications associated with weight gain. Ann Pharmacother 2005;39:2046-55. [Ref.ID 75965]
38. Cita con resumen
Wagena EJ, Knipschild PG, Huibers MJH, Wouters EFM, van Schayck CP. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonar disease. Arch Intern Med 2005;165:2286-92. [Ref.ID 75539]
39.
Mann JJ. The medical management of depression. N Engl J Med 2005;353:1819-34. [Ref.ID 75204]
40.
Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol 2005;45:1106-22. [Ref.ID 75076]
Seleccionar todas
 
<< anterior 21 a 40 de 108 siguiente >>